Cadre Holdings, Inc. Common Stock (CDRE)
Healthcare › Orthopedic, Prosthetic & Surgical Appliances & Supplies
Price History
Feb 9, 2026 — Jul 10, 2026Investment Snapshot
- Trading 148% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 10.2% — below-average profitability
- Revenue growing at 8% annually
Cadre Holdings, Inc. Common Stock (CDRE) is a Healthcare company operating in Orthopedic, Prosthetic & Surgical Appliances & Supplies, listed on the NYSE , with a market capitalisation of $1.3 billion . Key value metrics: P/E ratio 36.8, P/B ratio 3.76, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Cadre Holdings, Inc. Common Stock — Fundamental Analysis Summary
Cadre Holdings, Inc. Common Stock (CDRE) is currently trading 148% above its Graham Number of $11.91, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 36.8x.
On financial health, CDRE shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 10.2% (sector average: -20.6%), and elevated leverage with a debt-to-equity ratio of 1.09.
StockPik's composite Value Score for CDRE is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CDRE reports a solid gross margin of 41.3% (sector average: 39.4%) and a modest operating margin of 9.1%.
CDRE shows revenue growing at 8% year-over-year, with earnings growing at 22%.
CDRE pays a modest dividend yield of 1.3%.